Please assess the completion status of the following clinical trial:

Trial Title: Buprenorphine as a Treatment in Opiate Dependent Pain Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of chronic refractory pain~* Clinical diagnosis of opiate dependency~Exclusion Criteria:~* unable to pay for medication~* enrolled in a methadone maintenance program~* homelessness~* major mental illness~* pregnant women~* prisoners~* terminal cancer pain

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tapering doses of buprenorphine (Type: ACTIVE_COMPARATOR): Participants assigned to this arm will receive tapering doses of buprenorphine for detoxification.
- Steady doses of buprenrophine (Type: EXPERIMENTAL): Participants assigned to this arm will receive a steady dose of buprenorphine for maintenance.

Based on this trial design, predict the completion outcome and termination type (if applicable).